NCT06245122View on ClinicalTrials.gov

A Study of CS23546 in Subjects With Advanced Tumors

PHASE1RecruitingINTERVENTIONAL
Enrollment

156

Participants

Timeline

Start Date

March 27, 2024

Primary Completion Date

February 28, 2027

Study Completion Date

May 31, 2027

Conditions
Advanced Tumors
Interventions
DRUG

CS23546

Tablets administered orally.

Trial Locations (1)

Unknown

RECRUITING

Sun Yat-sen University Cancer Cancer, Guangzhou

Sponsors
All Listed Sponsors
lead

Chipscreen Biosciences, Ltd.

INDUSTRY